Bolaji Otike-Odibi
- Virology top 2%
- Poxvirus research and outbreaks 2
- Epidemiology top 10%
-
- Dermatology and Skin Diseases 2
- Hidradenitis Suppurativa and Treatments 2
- Medicine and Dermatology Studies History 1
-
- Autoimmune Bullous Skin Diseases 4
-
- Dermatological diseases and infestations 3
-
- Hair Growth and Disorders 2
-
- Drug-Induced Adverse Reactions 2
- Co-authors
- Michael IroezinduRegina OladokunOlusola ArunaDimie OgoinaAdesola Yinka-OgunleyeChikwe IhekweazuAyesha AkinkugbeOlusola Ayanlowo
- Partner nations
- NigeriaUnited Kingdom
In The Last Decade
Bolaji Otike-Odibi
15 papers receiving 358 citations
Hit Papers
Peers
Comparison fields: 5 of 39
- Virology 320
- Epidemiology 258
- Molecular Biology 267
- Dermatology 14
- Sensory Systems 7
Countries citing papers authored by Bolaji Otike-Odibi
This map shows the geographic impact of Bolaji Otike-Odibi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bolaji Otike-Odibi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bolaji Otike-Odibi more than expected).
Fields of papers citing papers by Bolaji Otike-Odibi
This network shows the impact of papers produced by Bolaji Otike-Odibi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bolaji Otike-Odibi. The network helps show where Bolaji Otike-Odibi may publish in the future.
Co-authorship network
The 14 scholars most cited alongside Bolaji Otike-Odibi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2021 | 0 | |
| 4 | 2021 | 0 | |
| 5 | Covid 19: A Prospective Observational Study on the Cutaneous Manifestations of Patients in Lagos, Nigeria. | 2021 | 1 |
| 6 | 2021 | 2 | |
| 7 | 2021 | 3 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 2 | |
| 10 | Clinical Course and Outcome of Human Monkeypox in Nigeriabreakdown → | 2020 | 327 |
| 11 | 2020 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 1 | |
| 14 | 2018 | 0 | |
| 15 | 2018 | 0 | |
| 16 | 2018 | 1 | |
| 17 | 2015 | 1 | |
| 18 | 2015 | 1 | |
| 19 | 2015 | 1 | |
| 20 | Characteristics of vitiligo in Lagos, Nigeria. | 2009 | 19 |
About Bolaji Otike-Odibi
Bolaji Otike-Odibi is a scholar working on Dermatology, Family Practice and Virology, having authored 20 papers that have together received 364 indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (4 papers), Dermatological diseases and infestations (3 papers), Hair Growth and Disorders (2 papers), Drug-Induced Adverse Reactions (2 papers), Dermatology and Skin Diseases (2 papers), Hidradenitis Suppurativa and Treatments (2 papers), Poxvirus research and outbreaks (2 papers) and Medicine and Dermatology Studies History (1 paper). The work is most often cited by research in Virology (320 citations), Epidemiology (258 citations) and Molecular Biology (267 citations). Bolaji Otike-Odibi has collaborated with scholars based in Nigeria and United Kingdom. Frequent co-authors include Michael Iroezindu, Regina Oladokun, Olusola Aruna, Dimie Ogoina, Adesola Yinka-Ogunleye, Chikwe Ihekweazu, Ayesha Akinkugbe, Olusola Ayanlowo, Yetunde Mercy Olumide and Akpabio Akpabio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.